Add-on Treatment with Rituximab Did Not Improve Lupus Nephrititis According to New Study
Wednesday, January 18, 2012
Results of a newly-published study showed that adding rituximab to mycophenolate mofetil and corticosteroids does not improve outcomes in patients with lupus nephritis. Rituximab is approved for treating Non-Hodgkin's lymphoma, a type of cancer of the immune system.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms